(DAN) Dana - Overview
Stock: Axles, Driveshafts, Seals, Cooling, Electrification
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.34% |
| Yield on Cost 5y | 1.93% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 92.3% |
| Payout Ratio | 33.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.8% |
| Relative Tail Risk | -9.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.70 |
| Alpha | 80.53 |
| Character TTM | |
|---|---|
| Beta | 1.564 |
| Beta Downside | 1.714 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.37% |
| CAGR/Max DD | 0.42 |
Description: DAN Dana January 13, 2026
Dana Incorporated (NYSE:DAN) designs and manufactures power-conveyance and energy-management components for a broad range of vehicles and industrial equipment, operating across four segments: Light Vehicle Drive Systems, Commercial Vehicle Drive & Motion Systems, Off-Highway Drive & Motion Systems, and Power Technologies.
In FY 2023 the company generated roughly $10.1 billion in revenue, with an adjusted EBITDA margin of about 9 % and free cash flow of $620 million, underscoring solid cash generation despite a modest 2 % year-over-year revenue decline driven by a slowdown in global light-vehicle production.
Dana’s growth outlook is tightly linked to two macro-drivers: the ongoing electrification of vehicles, which expands demand for its electric motors, inverters, battery-management and fuel-cell components; and the resurgence of freight and construction activity, which fuels demand for commercial-vehicle and off-highway drivetrain solutions.
Key sector trends include stricter emissions regulations worldwide and the acceleration of autonomous-driving technologies, both of which push OEMs toward more sophisticated, software-enabled power-train and motion-control systems-areas where Dana’s digital analytics and predictive-control offerings are positioned to capture incremental share.
For a deeper quantitative dive, the ValueRay platform offers a data-rich view of DAN’s valuation metrics and comparable peers.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 55.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.16 > 1.0 |
| NWC/Revenue: 11.37% < 20% (prev 14.81%; Δ -3.44% < -1%) |
| CFO/TA 0.05 > 3% & CFO 408.0m > Net Income 55.0m |
| Net Debt (3.12b) to EBITDA (537.0m): 5.81 < 3 |
| Current Ratio: 1.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (139.2m) vs 12m ago -4.07% < -2% |
| Gross Margin: 7.73% > 18% (prev 0.07%; Δ 765.9% > 0.5%) |
| Asset Turnover: 107.0% > 50% (prev 114.9%; Δ -7.97% > 0%) |
| Interest Coverage Ratio: 0.98 > 6 (EBITDA TTM 537.0m / Interest Expense TTM 173.0m) |
Altman Z'' 0.93
| A: 0.12 (Total Current Assets 4.13b - Total Current Liabilities 3.16b) / Total Assets 8.11b |
| B: 0.04 (Retained Earnings 297.0m / Total Assets 8.11b) |
| C: 0.02 (EBIT TTM 170.0m / Avg Total Assets 7.98b) |
| D: -0.11 (Book Value of Equity -749.0m / Total Liabilities 6.77b) |
| Altman-Z'' Score: 0.93 = BB |
Beneish M -3.05
| DSRI: 0.88 (Receivables 1.41b/1.70b, Revenue 8.54b/9.03b) |
| GMI: 0.91 (GM 7.73% / 7.06%) |
| AQI: 1.39 (AQ_t 0.22 / AQ_t-1 0.16) |
| SGI: 0.95 (Revenue 8.54b / 9.03b) |
| TATA: -0.04 (NI 55.0m - CFO 408.0m) / TA 8.11b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of DAN shares?
Over the past week, the price has changed by +9.65%, over one month by +22.45%, over three months by +48.50% and over the past year by +102.31%.
Is DAN a buy, sell or hold?
- StrongBuy: 2
- Buy: 4
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DAN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.1 | -17.5% |
| Analysts Target Price | 26.1 | -17.5% |
| ValueRay Target Price | 36.7 | 15.8% |
DAN Fundamental Data Overview February 07, 2026
P/E Forward = 12.6422
P/S = 0.3719
P/B = 3.1234
P/EG = 6.8516
Revenue TTM = 8.54b USD
EBIT TTM = 170.0m USD
EBITDA TTM = 537.0m USD
Long Term Debt = 2.56b USD (from longTermDebt, last quarter)
Short Term Debt = 693.0m USD (from shortTermDebt, last quarter)
Debt = 3.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.12b USD (from netDebt column, last quarter)
Enterprise Value = 5.58b USD (2.46b + Debt 3.53b - CCE 414.0m)
Interest Coverage Ratio = 0.98 (Ebit TTM 170.0m / Interest Expense TTM 173.0m)
EV/FCF = 54.73x (Enterprise Value 5.58b / FCF TTM 102.0m)
FCF Yield = 1.83% (FCF TTM 102.0m / Enterprise Value 5.58b)
FCF Margin = 1.19% (FCF TTM 102.0m / Revenue TTM 8.54b)
Net Margin = 0.64% (Net Income TTM 55.0m / Revenue TTM 8.54b)
Gross Margin = 7.73% ((Revenue TTM 8.54b - Cost of Revenue TTM 7.88b) / Revenue TTM)
Gross Margin QoQ = 8.56% (prev 7.13%)
Tobins Q-Ratio = 0.69 (Enterprise Value 5.58b / Total Assets 8.11b)
Interest Expense / Debt = 1.33% (Interest Expense 47.0m / Debt 3.53b)
Taxrate = 21.0% (US default 21%)
NOPAT = 134.3m (EBIT 170.0m * (1 - 21.00%))
Current Ratio = 1.31 (Total Current Assets 4.13b / Total Current Liabilities 3.16b)
Debt / Equity = 3.23 (Debt 3.53b / totalStockholderEquity, last quarter 1.09b)
Debt / EBITDA = 5.81 (Net Debt 3.12b / EBITDA 537.0m)
Debt / FCF = 30.57 (Net Debt 3.12b / FCF TTM 102.0m)
Total Stockholder Equity = 1.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.69% (Net Income 55.0m / Total Assets 8.11b)
RoE = 4.39% (Net Income TTM 55.0m / Total Stockholder Equity 1.25b)
RoCE = 4.45% (EBIT 170.0m / Capital Employed (Equity 1.25b + L.T.Debt 2.56b))
RoIC = 3.21% (NOPAT 134.3m / Invested Capital 4.18b)
WACC = 5.42% (E(2.46b)/V(6.00b) * Re(11.68%) + D(3.53b)/V(6.00b) * Rd(1.33%) * (1-Tc(0.21)))
Discount Rate = 11.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.85%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈95.6m ; Y1≈62.8m ; Y5≈28.6m
Fair Price DCF = N/A (negative equity: EV 912.3m - Net Debt 3.12b = -2.21b; debt exceeds intrinsic value)
EPS Correlation: 20.45 | EPS CAGR: -20.17% | SUE: -2.23 | # QB: 0
Revenue Correlation: -59.89 | Revenue CAGR: -4.44% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.43 | Chg30d=+0.112 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.19 | Chg30d=+0.340 | Revisions Net=+2 | Growth EPS=+175.8% | Growth Revenue=+2.5%